about
Intermittent versus daily therapy for treating tuberculosis in childrenNegligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosyCurrent trends and intricacies in the management of HIV-associated pulmonary tuberculosisLooking back to the future: predicting in vivo efficacy of small molecules versus Mycobacterium tuberculosisIn silico evaluation and exploration of antibiotic tuberculosis treatment regimensA multi-scale approach to designing therapeutics for tuberculosisClassic reaction kinetics can explain complex patterns of antibiotic action.Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patientsA prospective study of tuberculosis drug susceptibility in sabah, malaysia, and an algorithm for management of isoniazid resistance.Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection modelComputational pharmacology of rifampin in mice: an application to dose optimization with conflicting objectives in tuberculosis treatment.Feasibility of a fixed-dose regimen of pyrazinamide and its impact on systemic drug exposure and liver safety in patients with tuberculosis.High relapse rate in RNTCP: An increasing concern and time to intervene.Clinical profile and treatment outcomes of drug-resistant tuberculosis before directly observed treatment strategy plus: Lessons for the program.Diagnosis and management of TB in children: an update.Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.Therapeutic drug monitoring in the treatment of tuberculosis: an update.DOT, S, or DOTS?Applying optimization algorithms to tuberculosis antibiotic treatment regimens.Challenges of tuberculosis management in high and low prevalence countries in a mobile world.
P2860
Q24200978-B7741139-7642-4A1B-B4CD-346FB8E4819CQ26748597-AD520CAC-62B5-4F31-A5FB-C03C45E8D479Q28069032-B21A9B69-6BC4-48C3-8382-DA8FEE1B3EF3Q28538272-C63009C4-2C4C-4959-B193-ECB6A67D4172Q28607283-CA299FA3-AD43-4D8C-B035-F26D9E2CE6D2Q28647309-A769D2F4-78AC-4AA5-9FA2-101EE2AC56CEQ30662980-EB76D3DD-8364-452B-815D-B8EF1ED0104AQ34597564-CEA932A9-FDA0-4512-94C5-2E864C007ADCQ35206899-CDE792AC-9BFD-4C43-BC0A-74F7D69D27F1Q35864589-195E8200-F7BE-478A-9626-3835D67862B0Q36082913-E4C5DEF9-188D-4C1B-8E9F-2B6D702B7801Q36364005-E24D9A09-5335-4059-A69E-60238F8B90A3Q36817959-F199496B-7BE1-4EB8-9922-30D0B48BACB4Q37345726-3F2AB368-AEFB-48A6-A29F-0E24F07B64B2Q37960565-1D83B20F-8445-4E7B-ABFA-F61ED969FB99Q38040155-C38FC7B5-E071-4950-8DD9-7BB4C1762EAEQ38059150-35E969AC-FD86-4285-A3E8-2D752AFAD3DAQ38213320-6C980A76-B716-4AEE-A2B0-EA8C8E2C22C3Q41897620-251BA06A-1C86-45A2-9286-66848A1C630EQ47220472-28CCF8BA-ED78-47D4-B3CB-C11D6B28C5DCQ51103056-7846DECD-E1D8-4EBF-8E2B-91CC19C284EC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of tuberculosis and optimal dosing schedules.
@en
Treatment of tuberculosis and optimal dosing schedules.
@nl
type
label
Treatment of tuberculosis and optimal dosing schedules.
@en
Treatment of tuberculosis and optimal dosing schedules.
@nl
prefLabel
Treatment of tuberculosis and optimal dosing schedules.
@en
Treatment of tuberculosis and optimal dosing schedules.
@nl
P2093
P356
P1433
P1476
Treatment of tuberculosis and optimal dosing schedules.
@en
P2093
Chi Chiu Leung
Jacques Grosset
Kwok Chiu Chang
Wing Wai Yew
P304
P356
10.1136/THX.2010.148585
P407
P577
2010-12-17T00:00:00Z